4//SEC Filing
Cheng Sohanya Roshan 4
Accession 0001209191-23-036248
CIK 0001503802other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:07 PM ET
Size
5.3 KB
Accession
0001209191-23-036248
Insider Transaction Report
Form 4
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-06-08$2.35/sh−1,839$4,322→ 211,501 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 7, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
- [F2]Includes 2,653 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on April 28, 2023.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001865796
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:07 PM ET
- Size
- 5.3 KB